Cizzle Biotechnology Holdings Plc (FRA:E7F0)

Market Cap	5.20M -18.6%
Revenue (ttm)	n/a
Net Income	-757.19K
EPS	-0.00
Shares Out	n/a
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	161
Open	0.0110
Previous Close	0.0110
Day's Range	0.0110 - 0.0115
52-Week Range	0.0100 - 0.0395
Beta	n/a
Analysts	n/a
Price Target	n/a
Est. Earnings	Dec 29, 2026

About FRA:E7F0

Cizzle Biotechnology Holdings Plc, together with its subsidiaries, operates as a cancer diagnostics company in the United Kingdom. It develops a non-invasive blood immunoassay test for early lung cancer detection using CIZ1B biomarker technology. The company was formerly known as Cizzle Biotechnology Limited and changed its name to Cizzle Biotechnology Holdings Plc in May 2021. Cizzle Biotechnology Holdings Plc is headquartered in London, the United Kingdom.

• Industry: Biotechnology
• Sector: Healthcare
• Employees: 5
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: E7F0

Financial Performance

Financial numbers in GBP

Data Sources: S&P Global Market Intelligence and Twelve Data

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Twelve Data.

Last checked:

Oct 26, 2026

Data Sources Report a data error